These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2975406)

  • 1. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage.
    Jones DK; Luddington R; Higenbottam TW; Scott J; Cavarocchi N; Reardon D; Calvin J; Wallwork J
    Thromb Haemost; 1988 Oct; 60(2):199-204. PubMed ID: 2975406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma markers of endothelial cells and platelet activation following handgrip in normals and hypertensive patients.
    Musumeci V; Cardillo C; Baroni S; Tutinelli F; Guerrera G; Melina D; Savi L; Folli G
    J Clin Hypertens; 1987 Dec; 3(4):487-99. PubMed ID: 2839626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K; Fijnheer R; Rothova A
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura.
    Casonato A; Pontara E; Bertomoro A; Ossi E; Vincenti M; Girolami A; Borsatti A; Bertaglia G
    Am J Hematol; 1996 Jan; 51(1):7-11. PubMed ID: 8571941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial clustering of factor VIII and von Willebrand factor levels.
    Kamphuisen PW; Houwing-Duistermaat JJ; van Houwelingen HC; Eikenboom JC; Bertina RM; Rosendaal FR
    Thromb Haemost; 1998 Feb; 79(2):323-7. PubMed ID: 9493584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor.
    Holdright DR; Hunt BJ; Parratt R; Segal H; Clarke D; Taggart D; Bennett G; Collins P
    Eur J Cardiothorac Surg; 1995; 9(1):18-21. PubMed ID: 7727141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular reactivity, plasma markers of endothelial and platelet activity and plasma renin activity after mental stress in normals and hypertensives.
    Musumeci V; Baroni S; Cardillo C; Zappacosta B; Zuppi C; Tutinelli F; Folli G
    J Hypertens Suppl; 1987 Dec; 5(5):S1-4. PubMed ID: 2965225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII procoagulant antigen in human tissues.
    Kadhom N; Wolfrom C; Gautier M; Allain JP; Frommel D
    Thromb Haemost; 1988 Apr; 59(2):289-94. PubMed ID: 3133811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy.
    Palareti G; Biagi G; Legnani C; Bianchi D; Serra D; Savini R; Coccheri S
    Thromb Haemost; 1989 Dec; 62(4):1053-6. PubMed ID: 2533412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcium channel blockers on the endothelial release of von Willebrand factor after exercise in healthy subjects.
    Musumeci V; Cardillo C; Baroni S; Zuppi C; Zappacosta B; Tutinelli F; Folli G
    J Lab Clin Med; 1989 Apr; 113(4):525-31. PubMed ID: 2784824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation?
    Morariu AM; Gu YJ; Huet RC; Siemons WA; Rakhorst G; Oeveren WV
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):939-46. PubMed ID: 15519186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.